🔍 Search symptoms
Nutritional & Blood Disorders

Mast cell leukemia, in relapse

Emergency ICD-10: C94 · NIH NLM
हिंदी: मास्ट सेल ल्यूकेमिया · தமிழ்: மாஸ்ட் செல் லுகேமியா · ಕನ್ನಡ: ಮಾಸ್ಟ್ ಸೆಲ್ ಲ್ಯುಕೇಮಿಯಾ · తెలుగు: మాస్ట్ సెల్ లుకేమియా · বাংলা: মাস্ট সেল লিউকেমিয়া · मराठी: मास्ट सेल ल्युकेमिया · ગુજરાતી: માસ્ટ સેલ લ્યુકેમિયા
About this condition

Mast cell leukemia in relapse is an extremely rare and aggressive blood cancer where abnormal mast cells multiply uncontrollably after previous treatment. Patients experience severe allergic-like symptoms, organ damage, and blood abnormalities. This is a life-threatening condition requiring immediate hospitalization and intensive cancer therapy.

Common symptoms
severe allergic reactions skin flushing abdominal pain diarrhea bone pain fatigue weight loss dizziness
🚨
When to see a doctor: immediately
Take action
This condition in Indian languages
Hindi (हिंदी)मास्ट सेल ल्यूकेमिया · रक्त कैंसर पुनरावृत्ति · एलर्जी · पेट दर्द
Tamil (தமிழ்)மாஸ்ட் செல் லுகேமியா · இரத்த புற்றுநோய் · ஒவ்வாமை · வயிற்று வலி
Kannada (ಕನ್ನಡ)ಮಾಸ್ಟ್ ಸೆಲ್ ಲ್ಯುಕೇಮಿಯಾ · ರಕ್ತ ಕ್ಯಾನ್ಸರ್ · ಅಲರ್ಜಿ · ಹೊಟ್ಟೆ ನೋವು
Telugu (తెలుగు)మాస్ట్ సెల్ లుకేమియా · రక్త క్యాన్సర్ · అలెర్జీ · కడుపు నొప్పి
Bengali (বাংলা)মাস্ট সেল লিউকেমিয়া · রক্ত ক্যান্সার · এলার্জি · পেট ব্যথা
Marathi (मराठी)मास्ट सेल ल्युकेमिया · रक्त कर्करोग · ऍलर्जी · पोट दुखणे
Gujarati (ગુજરાતી)માસ્ટ સેલ લ્યુકેમિયા · લોહીનું કેન્સર · એલર્જી · પેટ દુખાવો
Frequently asked questions
What are the symptoms of Mast cell leukemia, in relapse?
severe allergic reactions, skin flushing, abdominal pain, diarrhea, bone pain, fatigue.
When should I see a doctor?
immediately
Is Mast cell leukemia, in relapse common in India?
This condition is seen across India.
How serious is Mast cell leukemia, in relapse?
Severity is classified as Emergency. immediately.
Related conditions
Important: This information is for general awareness only and is not a substitute for professional medical advice. Always consult a qualified doctor. In an emergency, call 112. Data sourced from NIH NLM and MOHFW India. Full disclaimer